BAX and acute myeloid leukemia: Both Bax and Bcl-2 have been confirmed to play critical roles in the leukemogenesis as well as multi-drug resistance of AML cells (Soderquist and Eastman, 2016; Pan et al., 2017; Reyna et al., 2017).